Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
AUTOR(ES)
Lyons, P R
RESUMO
A retrospective analysis of 350 treatment courses using high dose pulsed intravenous methylprednisolone for relapses of multiple sclerosis revealed a low number of adverse effects. This study confirms that high dose methylprednisolone is a safe therapeutic option in multiple sclerosis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1031546Documentos Relacionados
- A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
- Methylprednisolone in multiple sclerosis: a comparative dose study.
- Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.
- Methylprednisolone therapy in multiple sclerosis.
- Hyperbaric oxygen in chronic progressive multiple sclerosis: visual evoked potentials and clinical effects.
